Scientific Program – Fetomaternal Medicine

Saturday, November 23, 2024

 

08:30-09:00 GOOD MORNING LISBON PLENARY LECTURE HALL A

 

09:00-10:30 PRENATAL DIAGNOSIS AND GENETICS HALL D
Capsule
Chairpersons Asma Khalil, UK
Alvaro Cohen, Portugal
09:00-09:20

09:00-09:05
09:05-09:10
09:10-09:20

 Debate: Should we perform array-based comparative genomic hybridization for all

Yes:  Amir Aviram, Canada
No:
Discussion
09:20-09:40

09:20-09:25
09:25-09:30
09:30-09:40

 Debate: Should we perform whole exome sequencing for all?

Yes: Yariv Yogev, Israel
No:
Discussion
09:40-09:55 What is the value of genetic testing in small babies
Asma Khalil, UK
09:55-10:10  What are the true numbers of amniocentesis-related and chorionic-villus-sampling-related fetal losses?
Nir Melamed, Canada
10:10-10:30 Third trimester scan is not just a growth scan
Asma Khalil, UK

 

10:30-11:00 Coffee break, visit the exhibition, and e-poster viewing

 

11:00-12:30 OBESITY AND GESTATIONAL DIABETES MELLITUS (GDM) HALL D
Capsule
Chairpersons

Gerard Visser, Netherlands
Dan Farine, Canada
11:00-11:20

11:00-11:05
11:05-11:10
11:10-11:20

Debate: Should we screen and treat GDM prior to 24 weeks of gestation?

Yes: Gerard Visser, Netherlands
No: Eran Ashwal, Canada
Discussion
11:20-11:40

11:20-11:25
11:25-11:30
11:30-11:40

Debate: Should we counsel overweight/obese patients to lose weight during pregnancy?

Yes: Gerard Visser, Netherlands
No: Yariv Yogev, Israel
Discussion
11:40-11:50

What is a well-controlled patient in GDM?
Yariv Yogev, Israel
11:50-12:10

11:50-11:55
11:55-12:00
12:00-12:10

Debate: Should we induce all diabetic patients at 38 weeks of gestation?

Yes: Yariv Yogev, Israel
No: Gerard Visser, Netherlands
Discussion
12:10-12:25 Extreme obesity (BMI>50)
Dan Farine, Canada
12:25-12:30

Discussion

 

12:30-13:30 Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions

 

13:30-15:00 INDUCTION OF LABOR HALL D
Capsule
Chairpersons

Liran Hiersch, Israel
Nuno Clode, Portugal
13:30-13:50

13:30-13:35
13:35-13:40
13:40-13:50

Debate: Should all women be induced at 38-39 weeks of gestation?

Yes: Asma Khalil, UK
No: Liran Hiersch, Israel
Discussion
13:50-14:05

Should we use prostaglandins for cervical ripening in women with a previous cesarean?
Yariv Yogev, Israel
14:05-14:20

When to deliver patients with a single umbilical artery? with an umbilical vein varix?
Inês Nunes, Portugal
14:20-14:40

Cervical ripening at home for all? Mifepristone, Folley catheter ballon, and tafoxiparin
Maria Afonso, Portugal

14:40-15:00

14:40-14:45
14:45-14:50
14:50-15:00

Debate: To induce or not to induce large-for-gestational-age fetuses

Yes: Jim Thornton, UK
No: Emmanuel Attali, Israel
Discussion

 

15:00-16:30 FETAL GROWTH RESTRICTION (FGR) AND PRE-ECLAMPSIA HALL D
Capsule
Chairpersons

Asma Khalil, UK
Maria Afonso, Portugal

15:00-15:20

15:00-15:05
15:05-15:10
15:10-15:20

Debate: We can screen for pre-eclampsia but is treatment efficient?

Yes: Luisa Pinto, Portugal
No: Jim Thornton, UK
Discussion

15:20-15:35

When to recommend delivery in late-onset FGR?
TBA

15:35-15:55

15:35-15:40
15:40-15:45
15:45-15:55

Debate: Breaking growth curve during pregnancy not reaching the 10th percentile- A concern?

Yes: Nir Melamed, Canada
No: Jim Thornton, UK
Discussion

15:55-16:30

What is the best strategy to prevent recurrent pre-eclampsia- aspirin, low-molecular-weight heparin, statins, progesterone, combination of these?

Moderators:
Asma Khalil, UK
Yariv Yogev, Israel

Panel Discussion:
Nir Melamed, Canada
Jim Thornton, UK
Luisa Pinto, Portugal
TBA

 

Skip to content